Clinical value of 18F-FDG PET/CT in combination with mammography and ultrasound in diagnosis of breast cancer

Runqing Duan,Mengjie Dong,Jianxiu Xue,Bei Zhao,Xiang Qu,Yujin Zheng

DOI: https://doi.org/10.11655/zgywylc2015.03.008

2015-01-01

Abstract:Objective To explore the clinical value of 18F-fluorodeoxyglucose (18F-FDG) PET/CT in combination of mammography and ultrasound in diagnosing breast cancer. Methods A retrospective analysis of 36 patients with breast cancer after surgery was performed. The patients were divided into 3 groups (<1.0 cm, 1.0-2.0 cm and>2.0 cm). They had undergone preoperative ultrasound, molybdenum target X-ray mammography and PET/CT. We com-pared the diagnostic performance of these modalities. Results In the 6 patients with <1.0 cm tumor size, 18F-FDG PET/CT failed in all cases, while mammography and ultrasound detected the lesions in 4 and 2 cases, respectively. In the 19 patients with 1.0-2.0 cm tumor size, sensitivity of the PET/CT, ultrasound, mammography, alone and combina-tion of the three was 52.61%), 78.95%, 47.37% and 94.74%, respectively. There was no difference among the sen-sitivity of ultrasound, mammography and combined detection, while the PET/CT differed from the ultrasound and mam-mography in detection sensitivity ( χ2=4.94, P<0.05). For the cases with > 2.0 cm tumor size, the sensitivity was 81.82% with the X-ray mammography, 90.91% with the ultrasound, 90.91% with the PET/CT, and the 100% with combination of the three. In judgment of axillary lymph node metastasis of the breast cancer, the sensitivity, specifici-ty, accuracy, positive predictive value and negative predictive value were as follows: PET/CT (86.67%, 80.95%, 83.33%, 76.47%, 89.47%), ultrasound (66.67%, 61.90%, 63.89%, 55.56%, 72.22%), and molybde-num target (20.0%, 90.48%, 61.11%, 60.0%, 61.29%). Conclusion In diagnosis of <2 cm breast cancer, ultra-sound combined with mammography is more sensitive and affordable than PET/CT. When the tumor is greater than 2 cm, the three diag-nostic modalities offer similar sensitivity. Breast cancer of different pathological types show differ-ent 18F-FDG uptake.PET/CT appears to have evident advantages which justify it as reference for clinical purpose.